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Regulation of intracellular pH is responsible for many cellular processes, such 
as metabolism, cell cycle progression, and apoptosis.  Many chemotherapeutic 
agents work by inducing target cells to undergo apoptosis, a cell death process 
still poorly understood.  Previous studies demonstrated that a rise in intracellular 
pH activated apoptotic proteins leading to cytochrome C release.  This “apoptotic 
alkalinization” occurred upon activation of the plasma membrane protein, sodium 
hydrogen exchanger-1 (NHE1), whose activity is regulated by the stress kinase 
p38 MAPK.  In previous studies, upon cytokine withdrawal from cytokine-
dependent lymphocytes induced the activity of the p38 MAP kinase which then 
phosphorylated the C-terminus of NHE1.  To identify the p38 MAPK 
phosphorylation sites on NHE1, in vitro p38 MAP kinase assays coupled to 
deletion analysis of NHE1 and mass spectrometry, identified four possible p38 
MAPK phosphorylation sites.  To establish that NHE1 causes apoptotic 
alkalinization and determine whether the identified phosphorylation sites on 
NHE1 are functionally significant,   we used PCR site directed mutagenesis to 
mutate T717, S722, S725, and S728 on the C-terminus of NHE1.  Stable NHE1 
deficient cell lines, expressing wild type (WT) NHE or the four mutated sites 
(F4MUTNHE), were assessed for apoptotic alkalinization using the pH-sensitive 
fluorescent protein, destabilized YFP.  Our results show that NHE1 is required for 
apoptotic alkalinization, since expression of WT NHE restored alkalinization in 
an NHE deficient cell line, and that this process requires the phosphorylation of 
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1 CHAPTER ONE: INTRODUCTION 
1.1 Role of intracellular pH in apoptosis and proliferation 
 The regulation of intracellular pH is important in maintenance of cellular 
homeostasis. Oscillations in intracellular pH play a role in cell proliferation and 
survival but can also promote apoptosis.  Apoptosis, a form of programmed cell 
death, is a process which eliminates cells without an inflammatory response.  The 
events that set the stage for the effector phase of apoptosis are poorly understood.  
Mitochondrial breakdown, followed by cytochrome C release can be observed at 
an early stage of apoptosis.  Activation of caspase occurs at a late stage.  During 
apoptosis, DNA fragmentation occur during in the late stage of apoptosis.  Some 
of these apoptotic events have been correlated to changes in intracellular pH 
(Shrode, Tapper, and Grinstein;Coakley et al.).  Intracellular acidification is 
thought to activate DNase II, leading to DNA fragmentation during apoptosis, 
DNase II becomes active at < 6.0 pH.  Conversely, alkaline pH has been shown to 
activate apoptotic mechanisms, such as mitochondrial translocation of the 
apoptotic protein, Bax (Tafani et al.;Khaled et al.;Khaled et al.)  
Regulating intracellular pH is important in many cellular metabolic processes, 
such as egg fertilization, DNA replication rates, and regulation of cAMP (Busa 
and Nuccitelli).  One regulator of intracellular pH is NHE1 which effluxes 
protons in exchange for extracellular sodium when activated.  This activation 
prevents cells from acidifying as a result of metabolic activity.  NHE1 can be 
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activated by many regulatory proteins or kinases, all of which cause intracellular 
alkalinization. Depending on tissue specificity and stimuli, intracellular 
acidification can either inhibit or activate apoptosis.  Previous studies have shown 
that growth hormone stimulation or acidic conditions can cause Extracellular 
Signal-Regulated Kinase (ERK) to become phosphorylated, which leads to cell 
proliferation, cell migration, and survival (Wu et al.).  On the other hand, several 
studies have shown that if p38 MAPK activates NHE1 by stress stimuli, it can 
lead to apoptosis. 
Previous studies have shown that the translocation of Bax in response to a 
change in intracellular pH, due to the activation of the plasma membrane protein 
sodium hydrogen exchanger1 (NHE1) (Khaled et al.)   Cytokine-withdrawal 
activates p38 mitogen-activated protein kinase by an unknown mechanism, which 
then potentially phosphorylates the1 carboxyl terminus of NHE1.  The activation 
of NHE1 allows for extrusion of  protons and influx of sodium leading to a 
heightened alkaline response (Mahnensmith and Aronson).  Cellular stress, i.e. 
ultraviolet radiation, osmotic stress, heat or cytokine withdrawal can also activate 
p38 MAPK, which could potentially lead to apoptosis, through the activation of 
NHE1. 
1.2 Structure and function of the sodium hydrogen exchanger 
The sodium hydrogen exchanger (NHE) is a family of ubiquitous plasma 
membrane proteins, which catalyze the exchange of extracellular sodium for 
2 
intracellular hydrogen upon activation (Figure 1).  NHE is responsible for 
regulation of intracellular pH, cell volume, cell migration, and apoptosis (Fliegel).  
NHE is a family of ten isoforms (Table 2, p 49) which all share a similar 
topology. Each isoform consists of 815 amino acids, of which 500 make up the 
amino terminus, which is responsible for ion exchange transport across the plasma 
membrane.  The hydrophilic cytosolic domain consists of 315 amino acid, which 
is classified as a regulatory domain (Wakabayashi et al.).  NHE differs from other 
proton exchangers such as sodium bicarbonate exchanger (NBC), anion 
exchangers (AE) and the sodium driven chloride bicarbonate exchanger (NDAE), 
because it has a short N-terminus and long cytoplasmic domain (Putney, Denker, 
and Barber).   
NHE has a calculated molecular weight of 85-110 kDa, based on sequence.  If 
it is glycosylated (mature) the protein has an approximate molecular weight of  
110 kDa whereas if it is unglycosylated (immature) the molecular weight is 
around 85 KDa (Cavet et al.).  The only NHE isoform that possess N-linked and 
O-linked glycosylation sites is NHE-1 (Counillon, Pouyssegur, and Reithmeier).  
There are three N-glycosylation sites found in the transmembrane domain, Asn75, 
370, and 410, all have Asn-X-Ser/Thr motif.  The importance of NHE1 N-linked 
glycosylation, is not well understood, although it could potentially aid in correct 
folding conformation and transport to the plasma membrane.  N-linked 
glycosylation occurs co-translationally in the ER, whereas O-linked glycosylation 
occurs in the trans-golgi network (Counillon, Pouyssegur, and Reithmeier).  Sato 
et. al reported that just after transmembrane 9, loop ten translocates through the 
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membrane into the lumen, allowing sequestering of modifying enzymes that 
glycosylate this region after TM9.   
There are currently two models that describe the topology of NHE.  The 
model proposed by Wakabayashi et al consists of both the N-terminus and C-
terminus to be located in the cytosol, whereas another model proposes that the N-
terminus is located in the extracellular matrix (Counillon, Pouyssegur, and 
Reithmeier).  To date, there is no evidence to support either model.  The N-
terminus was identified by Kyte-Doolittle hydropathy analysis, to be comprised of 
12 alpha helices, which span across the plasma membrane allowing for ion 
transport.  The exact transmembrane domain loop needed for ion transport is 
unknown.  It has been proposed to be on intracellular loop 2 (TM 4 and 5) and 
intracellular loop 4 (TM 8 and 9) (Wakabayashi et al.)  The C-terminus secondary 
structure was determined to consist of 35 % alpha-helix, 17% beta-turn, and 48% 
random coil, and this was identified by circular dichroism (Gebreselassie, 
Rajarathnam, and Fliegel).  The C-terminus is proposed to function as a 
regulatory domain that modulates the activity of NHE1 (Wakabayashi et al.).  For 
example, an increase in calcium causes binding of calmodulin which can then 
functions as a signal transducer for the activation of NHE1 (Wakabayashi et al.).  
NHE1 is also regulated by several kinases such as Extracellular Signal-Regulated 
Kinase (ERK), Jun N-terminal kinase (JNK), and p38 MAPK, where all target the 
c-terminal residues (Khaled et al.;Takahashi et al.;Wang et al.).            
 The Sodium Hydrogen-1 (NHE1) isoform is of interest, because it is 
ubiquitously expressed on the basolateral plasma membrane of most epithelial 
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cells and its main function is regulation of intracellular pH and cell volume.   
Cell-surface receptors such as tyrosine kinase receptors, G protein coupled 
receptors, or integrin receptors activate NHE1 through binding of regulatory 
proteins, phosphorylation, or conformational changes which lead to a change in 
Hydrogen transport (Putney, Denker, and Barber).    
 
 
Figure 1: NHE1 proposed regulation 
1.3  Activators and inhibitors of NHE 
The sodium hydrogen exchanger can be activated by a variety of signaling 
molecules or regulatory proteins.  Signaling molecules become activated upon 
induction of stress due to serum starvation, ultraviolet radiation, or cytokine 
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withdrawal.  Wang et. al identified that mitogen-activated protein kinase (MAPK) 
regulates and phosphorylates NHE1 via the cytosolic domain.  Several mitogen-
activated protein kinases have been observed to phosphorylate NHE1, such as 
extracellular signal-regulated kinase (ERK), p90RSK, Nck-interacting Kinase 
(NIK), and p38 MAPK.  The phosphorylation of NHE1 leads to activation, which 
ultimately leads to a change in intracellular pH (Khaled et al.;Wang et al.;Yan et 
al.;Takahashi et al.;Haworth et al.).  NHE1 can also be activated by the binding of 
regulatory proteins such as Calcineurin B homologous protein (CHP), 14-3-3, and 
calmodulin.   
Even though NHE1 aides in the transport of sodium and hydrogen, calcium is 
very important for the activation of NHE1.  Cellular homeostasis requires 
regulation of both intracellular pH and intracellular calcium, without one or both 
many cellular function, (such as proliferation and skeletal movement) will be 
inhibited.  Both regulatory proteins, calmodulin and CHP, are dependent of 
calcium levels (Wakabayashi et al.;Lehoux et al.).  Several diseases have been 
identified to be caused by activation of NHE1 or MAPK (ERK and p38), such as 
heart ischemia and hypertrophy (Abe, Baines, and Berk).  NHE1, in heart 
ischemia, can be activated by a decrease or increase of intracellular pH.  This 
causes an intrusion of extracellular sodium, leading to an abundance of  
intracellular calcium (Masereel, Pochet, and Laeckmann). Thus inhibition of 
NHE1 has a protective effect during cardiac ischemia –reperfusion injury (Wang 
et al.).   
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In addition to the cellular regulatory molecules, there are also chemical 
compounds which can activate NHE1 directly and indirectly.  Phorbol esters, 
phosphatase inhibitors, staurosporine, or anisomycin can induce the 
phosphorylation of NHE1 leading to activation (Masereel, Pochet, and 
Laeckmann).  One NHE1 activator, anisomycin, activates it indirectly by 
inhibiting protein synthesis which causes a stress signal that leads to the  
phosphorylation of MEK3 and MEK6, leading to p38MAPK activation (Schaeffer 
and Weber).  Staurosporine was previously identified as a protein kinase inhibitor, 
but Vries-Seimon et al determined that it also activated protein kinases such as 
p38 MAPK (Vries-Seimon et al.).   
In addition to pharmaceutical activators, there are also several classes of 
inhibitors, such as amilorides and benzoylguanidines (Putney, Denker, and 
Barber) (Figure 2). Even though NHE isoforms have similar topology, their 
sensitivity to both classes of inhibitors is greatly different.  For example, HOE 
compounds (benzoylguanidines) are able to inhibit NHE1 but not NHE3.  The 
mechanism by which the inhibitors function is yet to be completely understood.  
Cardiac vessel damage occurs due to an increase in intracellular calcium. 
Amilorides may function by blocking sodium transport, which inhibits an increase 
in intracellular calcium, thus inhibiting cardiac vessel damage (Masereel, Pochet, 
and Laeckmann)  
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Figure 2:  NHE inhibitors (Putney, Denker, and Barber)  
1.4 Summary of thesis 
Regulation of intracellular pH via NHE1 is important for many cellular 
processes such as proliferation and survival, cell migration, and apoptosis.  
Previous studies reported that activation of p38MAPK leads to the 
phosphorylationand activation of NHE1,  which ultimately caused apoptosis 
(Khaled et al.;Khaled et al.;Coakley et al.). To examine the role of p38 MAPK in 
activation of NHE1, NHE1-GST fusion proteins were constructed with a series of 
deletions in the c-terminal regulatory domain.  Four phosphorylation sites (T717, 
S722, S725, and S728) on NHE1 were identified by p38 MAPK in vitro kinase 
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assay and were confirmed by mass spectrometry (Figure 3) (Khaled et al.).  Based 
on these initial findings we hypothesized that not only is NHE1 necessary for 
alkalinization during apoptosis, but that it can be phosphorylated by p38 MAPK 
within the putative four sites.  To determine if NHE1 is the mediator of apoptotic 
alkalinization, site directed mutagenesis was used to construct a mutant 
(F4MUTNHE) containing alanine residues in place of all four putative p38 
MAPK phosphorylation sites.  Cells expressing these constructs were then 
subjected to apoptotic stimuli and changes in intracellular pH were measured 
using destabilized yellow fluorescent protein (dEYFP) as read out for cytosolic 
pH.  Our results support the hypothesis that p38MAPK activates NHE1 by direct 




Figure 3:  NHE1 potential p38 MAPK phosphorylation sites 
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2 CHAPTER TWO: METHODOLOGY 
2.1    Cell Lines 
The Chinese hamster ovary cell line, CHO-K1 obtained from American Type 
Tissue Culture Collections, was cultured in Dulbecco’s Modified Eagle’s Medium 
with L-Glutamine, Sodium Pyruvate, 4.5 g/L Glucose and supplemented with 10 
% Fetal Bovine Serum and 1000 U/ml Penicillin/Streptomycin.  NHE-1 deficient 
CHO cells (AP-1) were a kind gift from L. Fliegel from the University of Alberta 
in Canada.  AP-1 cells were cultured in minimum essential alpha medium with L-
glutamine, ribonucleoside and deoxyribonucleosides and supplemented with 10% 
Fetal Bovine Serum, 1000 U/ml Penicillin/Streptomycin, and 25 mM Hepes.   
AP-1 cells co-transfected with wild type NHE-1 (PYN4) or mutant AP1 
(F4MUTNHE) (see below) and destabilized yellow fluorescent protein (dEYFP) 
were cultured in complete minimum essential alpha medium containing 500 
µg/mL geneticin.  Corning T25cm2 or T75cm2 flasks at 37◦C with 5% carbon 
dioxide were used for all cell lines. Cellstripper, a non-enzymatic cell dissociation 
solution, was added to dissociate adherent cells from flasks, and then incubated 
for 5 minutes at 37◦C and 5% CO2. 
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2.2   Plasmid construction and site direct mutagenesis 
    Site directed mutagenesis was performed using the pYN4+ plasmid to 
construct wild type (WT) and mutant NHE1 (F4MUTNHE).  The plasmid pYN4+ 
contains cDNA encoding for the human sodium hydrogen exchanger-1 isoform 
with a hemagglutinin (HA) tag on the C-terminus of the protein (Figure.  It also 
contains a Rous sarcoma virus (RSV) promoter, thymidine kinase poly (A) signal 
and neomycin resistance gene.  Through fluorescent automated DNA sequence 
analysis, our pYN4+ plasmid was found to contain an additional ApaI restriction 
site, than published sequence (see table1 for primers).  
 
Figure 4:  Pyn4+ plasmid 
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To construct F4MUTNHE mutant, PCR site directed mutagenesis was 
performed targeting residues T718, S723, S726, S729, by changing serines to 
alanines. An ApaI restriction digestion site was also added to facilitate ligation 
reactions (Table 1).  The PCR reaction contained 5 µl of 10x PCR buffer, 1.5 µl 
of 10 mM dNTP, 1 µl of 50 mM MgSO4, 1.5 µl of 10 mM Forward primer, 1.5 µl 
of Reverse primer, 1 µl of 100 ng/µl pYN4+, 1 µl of pfx DNA polymerase, and 
37.5 µl water.  PCR conditions for all amplifications were 94◦C for 3 minutes for 
one cycle; the next 25 cycles were as followed: 94◦C for 30 seconds, 65◦C for 30 
seconds, and then 72◦C for 30 seconds.  The last cycle was 94◦C for 7 minutes, 
and samples were then placed at 4◦C.  PCR products were analyzed on 1% 
Agarose gel.  Bands corresponding to our product (757 bp) were excised and 
purified with a gel extraction kit following manufacturer’s protocol (QIAGEN gel 
extraction kit).  Cloning and transformation was performed following 
manufacturer’s protocol for Zero blunt TOPO PCR cloning kit (Invitrogen).  After 
adding 4 µl PCR product, with 1µl salt solution, and 1 µl TOPO vector, the 
mixture was incubated at room temperature for 5 minutes.  Two microliters of 
TOPO reaction mixture was added to 1 vial of competent, and incubated on ice 
for 15 minutes.  The competent cells were then incubated at 42◦C for 30 seconds 
followed by 2 minutes on ice.  Fifty microliters of competent cells were added to 
250 µl of SOC media, the cutlture was then placed at 37◦C for 1 hour with 
constant agitation.  After the incubation,Luria-Bertani (LB) medium with 
Kanamycin (50 µg/ml) were inoculated with 100 µl, 50 µl, 25 µl of competent cell 
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mixture.  Clones were isolated.  DNA was extracted using a DNA maxi prep 
isolation kit following manufacturer’s protocol (QIAGEN Maxi prep).   
To subclone the F4MUTNHE into the pYN4 vector , the Zero blunt TOPO 
vector with F4MUTNHE PCR and pYN4+ vector were both digested using ApaI 
restriction enzyme, both plasmids were then analyzed on 1% agarose gel.  
Corresponding bands were extracted using QIAGEN gel extraction.  For ligation, 
1.4 µl pYN4+ (17 ng/µl) and 9 µl mutant PCR (8 ng/µl) was added to master mix 
containing 1 µl T4 Ligase, 4 µl 5X Ligase buffer, and 4.6 µl deionized water.  
After, the ligation mixture was incubated at 22◦C for 5 minutes, it was 
transformed into competent cells following previous protocol.  
 To determine whether a clone had the F4MUTNHE inserted in the correct 
orientation, they were digested with ApaI (previous conditions).  Correct 
orientation was identified by restriction digestion with AfI II and NheI.  After 
orientation was identified, the corresponding clones were sent for automated 
DNA sequence analysis to confirm the sequence.  See table 1 for primers used for 
sequencing.  
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Table 1: Primers used for sequencing and the construction of NHE1 mutant 
 
* All primers start at the 5’ end.  Lower case residues indicate mutations; 
italic residues indicate ApaI restriction sites. 
2.3 Co-Transfection of AP-1 with dEYFP and either wild-type NHE1 or F4MUTNHE 
 To establish a stable NHE1 expressing cell line, AP-1 cells (0.5x106) were 
plated in Corning six well tissue culture plates in 2 mL of complete minimum 
essential alpha medium overnight at 37◦C with 5% CO2.  When 75-80% 
confluence was met, the medium was removed and 2 mL of fresh medium without 
fetal bovine serum was added, and then, incubate for four hours at 37◦C with 5% 
CO2.  Lipofectamine 2000 was used to transfect AP-1 cells with either human 
cDNA wild type or F4MUTNHE, following a similar protocol to the 
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manufacturers protocol.  Briefly, two polystyrene cell culture tubes were setup 
with 250 mL of Minimum Essential Alpha medium (α-MEM) without FBS.  To 
one tube, 4 µg of DNA from Wild type or F4MUTNHE and 4 µg of dEYFP 
(destabilized yellow fluorescent protein vector Pd2EYFP-N1) were added; the 
other tube had 10 µl Lipofectamine 2000 added to medium.  After both tubes 
received the corresponding DNA they were incubated at room temperature for 
four minutes, then the two tubes were mixed together.  Five hundred microliters 
of mixed DNA in medium was added to each well, and then incubated at 37◦C 
with 5% CO2 for four to six hours.  Subsequently, 10% fetal bovine serum was 
added and then incubated overnight at 37◦C with 5% CO2.  After twenty-four 
hours, media was removed and 2 ml of fresh medium was added.  After thirty-six 
hours, cells were split and resuspended in complete medium with 800 µg/mL 
geneticin (Invitrogen); optimal geneticin concentrations were previously 
determined.  For the first three days medium was changed daily using complete 
medium with 800 µg/ml Geneticin.  After that, cells were changed every two days 
until they reached confluence with medium containing 500 µg/ml geneticin.  Once 
theses cultures were confluent, they were maintained in corning T25 or T75 flask 
with complete minimum essential alpha medium with 500 µg/ml geneticin.    
2.4 Detection of dEYFP 
 To identify if co-transfected cells were expressing dEYFP, cells were 
analyzed by flow cytometry using a BD FACSCalibur.  Cells were grown on T25 
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corning flasks overnight at 37◦C with 5% CO2, at 75% confluence, cells were 
stripped and resuspended in 1 ml of sorting buffer (1X PBS, 25 mM Hepes pH 
7.0, 5 mM EDTA, and 1% FBS).  Cells were then analyzed by flow cytometry 
equipped with a 488 nm Argon laser and analyzed with an emission of 530 nm 
(Green fluorescence).  
2.4.1 Cell sorting 
 To separate the high expressing dEYFP cells from the low expressing 
dEYFP cells, cell sorting was performed on a BD FACS Aria.  All transfected 
AP-1 cells were plated in a T75 corning flask overnight at 37◦C with 5 % CO2.  At 
optimal confluence, 70-80%, cells were stripped and resuspended in 3 ml of 
sorting buffer and placed in 12x75 mm cell culture tubes.  Cells were then sorted 
per protocol on BD FACS aria using 488 nm argon laser with an emission of 530 
nm (green fluorescence).  Parameters for sorting were set to acquire 50% of the 
fluorescent population.  After cells were sorted, they were plated in a T25 corning 
flask with 10 ml fresh complete media containing 25000 ug/mL of 
penicillin/streptomycin to prevent contamination.  After 4 hours, media was 
removed and 10 mL of fresh complete media containing 500 ug/mL Geneticin 
was added per flask.     
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2.5 Detection of NHE-1 
2.5.1 Detection of NHE1 by immunoblot 
 To identify if NHE1 expression was present, immunoblots were 
performed.  Whole-cell lysates were made using approximately 1 x 106 cells in a 
modified RIPA buffer (Khaled et al.) (50 mM Tris, 150 mM NaCl, 100% [ 
wt/vol] NP40, 10% [wt/vol] Sodium deoxycholate, 10% [wt/vol] Triton X-100, 
0.5M EGTA, 0.1M PMSF, 0.1M Benzamidine, 1 complete mini EDTA-free 
protease inhibitor cocktail tablet) (ROCHE).  Cells were incubated with 50-100µl 
RIPA buffer on ice for five minutes, followed by centrifugation at 13,200 RPM at 
4◦C for 6.5 minutes.  Lysates were removed and placed in new tubes.  
Approximately 100 µg protein was loaded on to 8-16% Tris-Glycine SDS 
gradient gels (invitrogen) and then transferred on to 0.2 µM Polyvinylidene 
fluoride (PVDF) membrane by Tris-Glycine transfer buffer (Invitrogen).  
Membranes were then incubated for 2 hours in phosphate buffer with 0.1% 
Tween (PBSt) with 10 % Milk.  Membranes were then washed three times for 
five minutes with PBSt, and then probed with (1:1000 dilution) mouse 
monoclonal NHE-1 antibody (Chemicon) in PBSt with 5 % milk and incubated 
overnight at 4◦C.  Membranes were then washed three times for five minutes each, 
followed by incubation with (1:2000 dilution) secondary antibody, goat anti-
mouse conjugated to HRP (Santa Cruz).  The membrane was developed using 
Supersignal West Pico Chemiluminescent Substrate (Pierce) following 
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manufacturer’s protocol.    To identify equal loading, GAPDH was probed using 
(1:1000 dilution) Anti-GAPDH mouse antibody (Ambion) in PBSt with 5% milk, 
and then with (1:2000 dilution) goat anti-mouse antibody in PBSt with 5% milk 
(Cell signaling).  The blot was developed using Pierce chemiluminescence as 
discussed methods.  Genesnap and Genetool from Syngene were used to 
determine density.      
2.5.2 Detection of NHE1 surface expression 
To identify if the transfected wild-type and F4MUTNHE cells were being 
expressing on the cell surface, transfected cells were treated with Proteinase K.  
All AP-1 transfected cell lines were plated in 6 well plates (1 x106 / ml) overnight 
at 37ºC with 5% CO2.  Media was removed when confluence was 70-80%, then 
100 µg/mL of proteinase K (invitrogen) in Tris-HCL (pH 7.4) and 1 M CaCl2 was 
added and incubated at 37ºC for 5 minutes.  PMSF (5 mM) was added and 
incubated for 2 minutes to stop the reaction.  Cells were then stripped and 
centrifuged for 10 seconds at 13,200 RPM on a tabletop centrifuge.  Cells were 
resuspended in cold PBS, and then centrifuged again.  The cells were then lysed 
in 25 µL of RIPA buffer and previously described immunoblot methods were 
followed (section 2.5.1).  
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2.5.3 Detection of NHE1 by confocal microscopy 
 To identify if NHE1 was expressing on plasma membrane, confocal 
microscopy was performed.  Before preparing 25 mm glass coverslips for 
confocal microscopy, they were washed three times with 70% ethanol.  Once dry, 
200 ug/mL of poly-L-lysine was added to each coverslip and incubated for 1 to 2 
hours at room temperature.  The coverslips were rinsed 3 times with PBS, then 
each was placed in a well of a 6 well corning plate.  AP-1 cells (0.5x106/ml) were 
added to each well containing a total of 2mL of complete media.  Coverslips were 
incubated overnight at 37◦C with 5% CO2, and grown until 70% confluence was 
met.  Then glass coverslips were removed from the media and washed three times 
with PBS.  The cells were then fixed and permeabilized with cold methanol for 5 
minutes.  Coverslips were then incubated in blocking buffer for 1 hour, followed 
by incubation with 1:25 dilution of HA antibody (Santa Cruz) in blocking buffer.  
Glass coverslips were then washed 3 times with PBS.  Cells were then incubated 
for 1 hour with (1:200) donkey anti-mouse Cy-5 (Jackson immunological) in 
blocking solution.  The coverslips were then washed three times with PBS.  A 
drop of Prolong anti-fade solution was placed on glass slides; coverslips were 
placed on top face down and incubated at room temperature in a dark area for 1 to 
2 hours to allow complete dryness.  The slides were then placed in the dark at 4ºC 
for storage.  Slides were analyzed using ZEISS confocal microscope LSM 510 
NLO at 100X using immersion oil. 
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2.6 P38 MAPK in vitro activity 
 For the detection of phosphorylated p38MAPK, a modified p38 mitogen 
activated protein kinase non-radioactive kit from Cell signaling was used.  AP-1 
cells were plated (0.5 x106) in six well plates overnight at 37◦C with 5% CO2.   At 
75-80 % confluence, 1 µM staurosporine was added to corresponding wells.  Cells 
were then harvested and resuspended in 100 µl 1X ice-cold lysis buffer plus 1mM 
PMSF, then incubated on ice for 10 minutes.  Cells were then centrifuged at 
13,200 RPM for 15 minutes at 4◦C.  Supernatant was transferred into new 
centrifuge tubes, and kept at -80◦C for later use.  Ten microliters of resuspended 
immobilized phospho-p38 MAP kinase monoclonal Antibody was added to 100µl 
of cell lysate and was then gently rocked overnight at 4◦C.  After samples were 
washed, the pellets were resuspended in 25µl of Master mix constituting 1X 
kinase buffer supplemented with 200 µM ATP and 2µg ATF-2 fusion protein 
substrate with and without 20µM PD169316 (p38 MAPK inhibitor) and 200µM 
DMA (NHE1 inhibitor) inhibitors.  Next, the samples were incubated for thirty 
minutes at 30◦C, followed by the addition of 25 µl 3X SDS with 2X Tris-glycine 
SDS sample buffer to terminate the reaction.  Samples were then run on 8-16% 
Tris-Glycine SDS gel, and then transferred to 2.0 µM Nitrocellulose membrane.  
The membrane was washed 3 times in PBSt, and then incubated in 5% milk in 
PBSt for one hour.  It was then washed 3 times in PBSt, and then incubated in 
phospho-ATF2 (thr76) (1:1000 dilution) in 5% BSA in PBSt overnight at 37◦C.  
The membrane was washed 3 times with PBSt, and then incubated for 1 hour in 
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5% BSA with (1:2000 dilution) HRP-conjugated secondary antibody and (1:1000 
dilution) HRP-conjugated anti-biotin. The membrane was washed 3 times with 
PBSt, and then developed following manufacturers protocol.   
2.7 Detection of intracellular pH 
2.7.1 Detection of intracellular pH BCECF-AM 
 BCECF-AM (Molecular probe) was used for the detection of intracellular 
pH. Cells (0.5 x 106) were plated and incubated at 37◦C with 5% CO2 overnight in 
tissue culture six well plates.  At 70-80 % confluence, cells were harvested and 
resuspended in Hepes pH buffer (25 mM Hepes, 140 mM NaCl, 5 mM KCL, 0.8 
mM MgCl2, and 5.0 mM glucose) with 1 µM BCECF-AM.  The cells were 
incubated for 20 minutes at 37◦C without CO2.   For calibration, 1 x 106 cells were 
resuspended in 1ml high potassium Hepes buffer (25 mM Hepes, 145 mM KCL, 
0.8 mM MgCl2, and 5.5 mM Glucose) at specific pH standards and supplemented 
with 13.8 mM Nigericin. They were then incubated for 20 minutes at 37◦C 
without CO2.  For samples, 1x 106 cells were resuspended in Hank’s balanced salt 
solution, with an addition of 10 ug/ul Anisomycin (ICN) to corresponding wells.  
Sample cells were incubated for 30 minutes at 37◦C without CO2.  Calibration 
and experiment samples were read on BD FACS Calibur excited with a 488nm 
argon laser, with an emission of 530 nm.  The pH values were determined by a 
standard pH calibration curve, which was determined by taking the absorbance 
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ratio between FL1H and FL3H.  Actual pH values were determined by taking the 
ratio between FL1-H and FL3-H of experiment samples then correlating them to a 
pH value on the standard calibration curve.       
2.7.2 Detection of intracellular pH using dEYFP  
Cell lines stably expressing dEYFP, were used to determine pH within 
varying environments.  Cells were plated in T75 tissue culture flasks overnight at 
37◦C with 5% CO2.  Calibration curve was determined by first harvesting cells at 
70-80% confluence.  Cells were centrifuged at 18,000 g for 3 minutes, then 
resuspended in 1 mL high potassium Hepes buffer at specific pH values and 
supplemented with 10 µM Nigericin.  Incubated for 20 minutes at room 
temperature in the dark, cells were then analyzed with BD FACS Calibur with a 
488nm argon laser with emission of 530 nm (green fluorescence).  Cells were 
centrifuged at 18,000 g for 3 minutes, then resuspended in 1 ml PBS pH Hepes 
Buffer (1X PBS, 1% Fetal bovine serum, and 25mM Hepes buffer) in cell culture 
tubes.  Twenty micromolar of PD169316 (p38 MAPK inhibitor), 200 µM 5, N-N-
Dimethyl-amiloride (NHE-1 inhibitor), or staurosporine (p38 activator) (0, 10 
pM, 100 pM, 1 nM, 10 nM, 100 nM, 1 µM, 10µM) was added to corresponding 
cell culture tubes.  After thirty minutes the negative control and staurosporine 
sample was analyzed.  After one hour 1 µM staurosporine was added to the 
inhibitors tubes and incubated again for thirty minutes at 37◦C with 5% CO2, and 
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then analyzed.  Analysis was performed on BD FACS Calibur with a 488nm 
Argon laser with 530 nm emission  (green fluorescence).   
24 
3 CHAPTER THREE: RESULTS 
Previous studies showed that withdrawal of cytokines from cytokine-
dependent lymphocytes induced the activity of the p38 MAP kinase, which in turn 
phosphorylated the C-terminus of NHE1.  Four p38 MAPK phosphorylation sites 
on NHE1 were identified by deletion analysis and confirmed by mass 
spectrometry.  Our hypothesis is that activation of key sites on NHE1 by p38 
MAPK is necessary to induce apoptotic alkalinization.     
3.1 NHE1 protein expression 
To establish that NHE1 causes apoptotic alkalinization and identify the 
regulatory phosphorylation sites on NHE1, we used PCR site directed 
mutagenesis to mutate the four potential phosphorylation sites (T717, S722, S725, 
and S728) in the C-terminus of NHE1 from serine or threonine to alanine.  NHE1 
deficient cells (AP-1) were co-transfected with dEYFP and wild type NHE1 or 
F4MUTNHE constructs.  After the cells were stably transfected, protein 
expression detected by immunoblot using an anti-NHE1 monoclonal antibody 
(Chemicon).  In Figure 3, NHE1 protein expression was observed in all 3 lanes, at 
approximately 100kDa.   
Since NHE1 is a 12 transmembrane protein, we next want to determine if 
NHE1 was being expressed on the cell surface.  The molecular mass of NHE1 
varies from approximately 100 kDa (mature) to 75 kDa (immature).  This 
variability is due to the glycosylation state.  The mature form occurs when the 
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protein is processed in the golgi and ER and then expressed on the cell surface.  
When an immature state is observed, one can conclude that it was not processed 
and exported to the plasma membrane.  The mature state has two glycosylation 
sites N-linked and O-linked on the transmembrane domain, by incubating with 
proteinase K at 100µg/mL, the NHE1 surface protein was digested leaving only 
the immature state.  Figure 5 shows AP-1 (NHE1 deficient cells), wild-type 
NHE1 expressing AP-1 cells, and F4MUTNHE expressing AP-1 cells.  The A and 
B refer to different clones.  Lanes 5-9 are untreated; therefore both mature and 
immature forms can be visualized.  When the samples were treated with 
proteinase K (Lanes 1-4), the mature form of NHE was digested leaving only an 
immature state, indicating that NHE1 is being expressed on the cell surface. 
We next confirmed that  NHE1 was being expressed on the plasma membrane 
by confocal microscopy.  Both the wild-type NHE1 and F4MUTNHE contain a 
triple HA tag at the carboxyl terminus of NHE1 protein, therefore we are able to 
use a hemagglutinin (HA) antibody as a probe to determine NHE1 localization.  
Cells were prepared on coverslips following the protocol described in the 
Materials and Methods.  For wild-type NHE1 expressing cells (Figure 6A), a HA-
probe conjugated to Rhodamine was used for labeling, whereas for F4MUTNHE 
cells (Figure 6B) a HA probe was followed by donkey anti-mouse CY7 (Jackson 
immunological).  In both figures, a distinct red labeled punctuation can be 
observed around the plasma membrane, thus NHE1 is being expressed on the 
surface of the plasma membrane.  
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Figure 5: Detection of NHE1 protein expression 
To confirm NHE1 protein expression, transfected AP-1 cells were lysed, and 
electrophoresed on a SDS 8%-16% gradient gel.  The PVDF membrane was 
incubated with mouse anti-Na/H exchanger monoclonal antibody followed by 
autoradiography as described in materials and methods. Lane 1 AP-1 cells (NHE1 
-/-), lane 2 Wild-type NHE1, and lane 3 F4MUTNHE all are expressing NHE1 at 
approximately 100 kDa.  
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Figure 6:  Surface expression of NHE1 confirmed by proteinase K digestion 
To confirm protein surface expression, proteinase K was used to digest 
surface proteins.  AP-1, Wild-type NHE1, and F4MUTNHE expressing cells were 
incubated with Proteinase K (lane 1-4) to degrad the NHE1 surface protein. Lanes 
5-9 were not incubated with proteinase K.  The two bands observed in lanes 5-9 
show a mature glycosylated form (undigested) of NHE1, whereas in lane 1-4, 
after digestion, only show the lower band consistent with the internal 





Figure 7: Conformation of surface expression of NHE1 
To confirm NHE1 was being expressed on the cell surface, wild-type NHE1 
and F4MUTNHE expressing cells were subjected to confocal imaging. (A) AP-1 
cells transfected with wild-type NHE1 has NHE1 localized on the plasma 
membrane.  (B) AP-1 cells were transfected with F4MUTNHE1 cells are 
expressing NHE1 on the plasma membrane.  Cells were processed and analyzed 
as described in Materials and Methods for HA-probe. 
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3.2 Destabilized YFP expression  
After determining NHE1 protein expression; dEYFP expression also had to be 
confirmed in cells stably co-transfected with destabilized YFP (dEYFP) and either 
wild-type NHE1 or F4MUTNHE1.  Destabilized YFP is a variant of the green 
fluorescent protein.  The significance of YFP versus GFP is that it can be used as 
an indicator of intracellular pH at pH > 6.0, whereas GFP detects acidic pH 
changes.  dEYFP expression was determined by BD FACS, with an excitation of 
488 nm, and an emission of 530nm.  Figure 7 shows presort expression and post 
sort expression of dEYFP in AP-1, wild-type NHE1, and F4MUTNHE cells.  The 
purpose of sorting the high expressers was to obtain a single peak, which could be 
monitored for shifts in response to pH change.  Multiple populations can be seen 
in figure 7 A-D, because it is a presorted population, whereas after sorting only a 
single peak is observed in E-G.  This allows for accurate detection of spectral 





 Figure 8: Stable dEYFP expression in transfected AP-1 cell lines  
Destabilized YFP expression was determined by excitation with 488 nm argon 
laser, and excited at 530 nm.  The X axis is dEYFP expression emission; the Y 
axis signifies cell count number.  Figure A-D shows the dEYFP expression before 
sorting, whereas Figures E-G, are representative of the sorted population of 







3.3 Intracellular pH calibration   
Different intracellular pH indicators have been used by others.  Our initial 
studies were performed using the pH-sensitive fluorescent dye 2',7'-bis-(2-
carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM).  
Shown in Figure 8, are several examples of calibration samples using BCECF.  
Consistent results were not achievable when determining the ratio between the 
535 nm and 610 nm.  Such variability did not occur with the use of dEYFP.  Due 
to this inconsistency, destabilized YFP was used as our indicator of intracellular 
pH changes.   
To identify if dEYFP could be calibrated in AP-1 cell lines, cells were 
transfected with dEYFP (Figure 9).  AP-1, wild-type NHE1, and F4MUTNHE 
cells were harvested and resuspended in a high potassium buffers and calibrated 
to different ranges of pH (7.0 - 8.0) along with 10 µM of Nigericin and incubated 
at room temperature for 30 minutes in the dark.  Nigericin is an ionophore, which 
exchanges hydrogen for potassium, allowing for the cytosol to become equivalent 
to the pH buffer.  After 30 minutes, samples were analyzed using a 488 nm Argon 
laser, with an emission of 530 nm.  Unlike BCECF, destabilized YFP does allow 
for accurate intracellular pH calibrating.  Figure 10 is representative of greater 




Figure 9:  Wild-type cells calibrated using BCECF  
To generate a calibration curve, Wild type NHE1 expressing cells were 
incubated with BCECF for 5 minutes at 37ºC, and then analyzed on BD FACS 
Calibur which is excited with a 488 Argon laser. The fluorescence of BCECF was 
determined by taking the ratio between the emissions (485 nm)/ (430 nm).  Each 





Figure 10: Wild-type cells calibrated using dEYFP 
Wild type NHE1 expressing AP-1 cells were incubated with 10 µM of 
Nigericin in different pH high potassium buffers for 20 minutes at room 
temperature, and then excited by 488 nm Argon laser.  The Y-axis is emission of 
dEYFP, whereas the X-axis represents of the different pH buffers used to 
calibrate the cells.  This figure is representative of > 50 similar experiments 
performed. 
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3.4 Effect of staurosporine on p38 MAPK activity and alkalinization 
We next needed to determine if staurosporine, a known protease inhibitor, 
could activate p38 MAPK and thereby activate NHE1 (Figure 11).   Wild-type 
NHE1 expressing AP-1 cells were incubated with varying concentrations of 
staurosporine (0 pm, 10 pM, 100 pM, 1 nM, 10 nM, 100 nM, 1 µM, 10 µM) at 
37ºC with 5% CO2 for 30 minutes.  Each sample was then lysed and the cytosolic 
extracts were immunoprecipitated with phosphorylated p38 MAPK antibody.  p38 
MAPK activity was determined by use of an in vitro kinase assay as described in 
the materials and methods (Section 2.6).  As shown in Figure 10, p38 MAPK is 
activated by staurosporine, with an optimal activity greater than 1nM  
Because p38 MAPK can be phosphorylated by staurosporine, we next wanted 
to determine if the addition of staurosporine could cause alkalinization (Figure 
11).  Wild-type NHE1 expressing cells were harvested and either prepared for 
calibration or for the pH determination experiment following previously described 
methods.  After the cells were incubated in staurosporine for 30 minutes, they 
were analyzed by BD FACS Calibur with and excitation of 488 nm and an 
emission of 530 nm.  When wild-type NHE1 expressing cells were exposed to 
different staurosporine concentrations, only 1 µM and 10 µM doses elicited a rise 
in intracellular pH.  This data does not parallel with the optimal concentrations 
that induced p38 MAPK activity in figure 11.  A possible explanation is that only 
cytosolic p38 MAPK was isolated and used in the in vitro kinase assay.  The 
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higher concentrations of staurosporine may induce change in the intracellular 
localization of p38MAPK, such that the kinase may have translocated to the 
nucleus, or associated with the membrane complexes. This may indicate that high 
concentrations of staurosporine can activate p38 MAPK in a manner that enables 




Figure 11:  p38 MAPK activation via staurosporine stimulation.  
Wild-type NHE1 expressing AP-1 cells were incubated with staurosporine for 
30 minutes, followed by cell lysis.  Cytosolic protein extracts were assayed for 
p38 MAPK activity using an in vitro kinase assay (Cell Signaling) following 
manufacture’s protocol.   
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Figure 12: Wild-type NHE1 cells responded to varying staurosporine concentrations 
Wild type NHE1 expressing cells were incubated with varying staurosporine 
concentrations from 0 pM to 10 µM for 30 minutes.  Intracellular pH was 
determined by dEYFP as described in the Materials and Methods.       
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3.5 NHE1 effect on apoptotic alkalinization 
We next wanted to determine if activated p38 MAPK could phosphorylate key 
site(s) on NHE1 to cause apoptotic alkalinization.  In figures 12-14, all cell lines 
were assayed using the same parameters.  AP-1, wild-type NHE1, and 
F4MUTNHE expressing AP-1 cells were harvested, and then resuspended in 
either pH buffers containing 10 µM Nigericin or with a PBS pH buffer (1X PBS, 
1% FBS, and 25 mM Hepes.  Both NHE1 inhibitor (DMA) and p38 MAPK 
inhibitor (PD169316) were added to corresponding tubes, after the addition of 
staurosporine, samples were analyzed with an excitation of 488 nm and emission 
of 530 nm.  The reason DMA and PD169316 were used, was to determine if the 
apoptotic alkalinization was due to the activation of NHE1 and if it was regulated 
by p38 MAPK.       
AP-1 cells which are devoid of NHE1 activity were treated with staurosporine 
or staurosporine with inhibitors.  There was no visible effect on intracellular 
(Figure 12).  In the absence of NHE1, AP-1 cells do not alkalinize, and these are 
not inhibited by DMA or PD169316. 
Expressing wild-type NHE1 in AP-1 cells restored normal NHE1 activity, 
when treated with staurosporine.  After the addition of both inhibitors, a decrease 
in alkalinization was observed.  This indicated that not only is NHE1 necessary 
for alkalinization, but also that NHE1 was regulated p38 MAPK (Figure 13). 
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After demonstrating restoration of NHE1 activity by expression of wild-type 
NHE1, we next wanted to determine if the four putative p38 MAPK 
phosphorylation sites, previously identified by in vitro kinase assay, were 
necessary for activity.  F4MUTNHE cells, which contain Alanines in place of 
threonine 717, serine 722, serine 725, and serine 728, were assayed using the 
same method discussed above.  Alkalinization in response to staurosporine was 
not restored by expression of F4MUTNHE1 in AP-1.  Like the AP-1 cells, 
F4MUTNHE expressing cells were not able to alkalinize through NHE1 in 
response to apoptotic stimuli (Figure 14). 
Wild-type NHE1 expressing cells displayed the only statistically significant 
difference (p< .00000136) between the negative control and staurosporine 
treatment.  Because F4MUTNHE1 expressing cells did not alkalinize, we 
conclude that induction of apoptotic alkalinization in response to staurosporine is 
due to the activation of p38 MAPK phosphorylation the putative site(s) of NHE1 




 Figure 13: Apoptotic alkalinization assay of AP-1 
AP-1 cells transfected with dEYFP were incubated with 1 µM staurosporine 
(STS) with and without 200 µM DMA (NHE1 inhibitor) or 20 µM PD169316 
(p38 MAPK inhibitor) and then excited with a 488 nm argon laser, with an 




Figure 14:  Apoptotic alkalinization of wild-type NHE1  
Wild-type NHE1 expressing AP-1 cells, transfected with dEYFP were 
incubated with 1 µM staurosporine (STS) with and without 200 µM DMA (NHE1 
inhibitor) or 20 µM PD169316 (p38 MAPK inhibitor) and then excited with a 488 
nm argon laser, with an emission of 530 nm.  The P values were calculated using 
Microsoft Excel T-test.  The * symbolizes the P value was significant with < 0.05.  




Figure 15: Apoptotic alkalinization of mutant NHE1  
F4MUTNHE expressing AP-1 cells transfected with dEYFP, were incubated 
with 1µM staurosporine (STS) with and without 200µM DMA (NHE1 inhibitor) 
or 20 µM PD169316 (p38 MAPK inhibitor) and then excited with a 488 nm argon 
laser, with an emission of 530 nm.  This is represented by n=11. 
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4 CHAPTER FOUR: DISCUSSION  
The sodium hydrogen exchanger is a family of proteins with 10 different 
isoforms.   NHE1 is important because it is ubiquitously expressed on the plasma 
membrane of most epithelial cells, and its primary role, is the regulation of 
intracellular pH.  Activated NHE1 regulates intracellular pH by extruding protons 
and importing extracellular sodium ions.  NHE1 is regulated by mitogenic stimuli 
such as growth hormone, osmotic stress, ultraviolet radiation, and cytokine 
withdrawal, which can activate several kinase pathways such as p38 MAPK, 
ERK, JNK, and NIK (Wang et al.;Abe, Baines, and Berk;Yan et al.).  Our data 
suggests NHE1 has a normal function in response to growth signals to maintain 
intracellular pH and during apoptosis its function is subverted to promote cell 
death.  
Normal function of NHE1 activity is regulated by mitogenic stimulation such 
as growth factors.  The presence of growth factors has been determined to directly 
activate NHE1 by activating ERK which then phosphorylates the downstream 
kinase p90RSK.  Phosphorylation of p90 ribosomal S6 kinase then in turn 
phosphorylates Serine 703 on the carboxyl terminus of NHE1(Takahashi et al.).  
It was recently shown, that the phosphorylation of S703 creates a docking site for 
Â14-3-3 protein, this binding allows for NHE1 regulation (Lehoux et al.).  
Proliferation and cell survival in other models have also been linked to 14-3-3 
binding.  ERK activation has been identified as a dependent mechanism for 
survival and proliferation.  The proposed model described by Wu et al, shows 
phosphorylated ERM can bind to the carboxyl terminus (S703) of NHE1, which 
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act as a scaffolding protein to recruit other signaling complexes leading to  
activation of AKT, a known anti-apoptotic protein.  In contrast, the role of 
activated NHE1 in apoptosis is far different.   
NHE1 has always been associated with cell survival, because of its established 
role in cell proliferation, but recently it was identified also as a regulator of 
apoptosis (Khaled et al.;Wu et al.).  Many recent publications in literature support 
the hypothesis that NHE1 activation leads to intracellular alkalinization, which 
activates downstream regulators such as AKT leading to an anti-apoptotic effect.  
In contrast, recent studies also determined that NHE1 activation also leads to 
apoptosis.  NHE1 activation was found to induce the translocation of Bax to the 
mitochondria, which activates cytochrome c release causing apoptosis (Khaled et 
al.;Khaled et al.;Coakley et al.).  The discovery that NHE1 is phosphorylated by 
p38 MAPK identified a new method to identify an early stage of apoptosis that 
takes place before mitochondrial breakdown during cytochrome C a caspase 
activator during late stage apoptosis.  
In our studies we determined that p38 MAPK activates NHE1 by 
phosphorylation of one or more of the four putative sites on NHE1.  The exact 
phosphorylation site(s) is not known and one or more sites may be involved.  
However, the established phosphorylation motif of p38MAPK is a serine-proline 
motif, so we can propose that two sites, Serine 723 and Serine 726 followed by 
prolines, could be involved in regulation of apoptotic alkalinization.  The putative 
p38MAPK sites on NHE1 may also have additional functions essential for pH 
homeostasis. 
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 In addition to p38MAPK, other kinases activated by diverse signaling 
pathways may also target NHE1.  Figure 15 represents the current model for the 
role of NHE1 in cell growth and apoptosis.  The difference between the two 
pathways is that ERK activation of NHE1 through phosphorylation of Serine 703 
leads to cell proliferation and survival, whereas stress stimuli causes p38 MAPK 
activation phosphorylating NHE1 at a different site(s), causing apoptotic 
alkalinization.  The different outcome of the two pathways may be due to the 
magnitude of the change in pH through NHE1 activation.  Phosphorylation of 
NHE1 through ERK in response to growth factors results in a pH change of less 
than 0.2 pH units, while stress/apoptotic stimuli activates p38MAPK resulting in a 
pH change of greater than 0.2 pH unit (Wu et al.).   
The significance of these findings is the potential to develop a novel way to 
detect early apoptosis through stress stimulated phosphorylation of NHE1 through 
p38MAPK activation.  NHE1 phosphorylated at one or more of the punitive 
p38MAPK sites could be used as a read out to characterize the effect of 
pharmaceuticals upon disease parameters regulated by NHE1 activity.  Future 
studies will be focused on identifying the exact p38 MAPK phosphorylation 
site(s) on NHE1 carboxyl domain, determining the functional consequences of 
phosphorylation of the sites on NHE1 in healthy and apoptotic cells, and finally 
producing an antibody for detection of p38 MAPK phosphorylated form of 






Figure 16:  Model of regulation of apoptosis via p38 MAPK activated NHE1 
(A) Normal NHE1 function: In the presence of growth factors, ERK is up 
regulated leading to both 14-3-3 binding, an also scaffolding of signaling complex 
needed for AKT activation, both of which promote cell survival.  (B) Apoptotic 
NHE1 function:   In the presence of stress stimuli such as cytokine withdrawal, 
p38 MAPK becomes activated which then phosphorylates NHE1 causing 
apoptotic alkalinization.  This alkalinization allows for BAX to translocate to the 
mitochondria, which causes cytochrome c release leading to apoptosis.  
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APPENDIX A: NHE family of isoforms 
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Table 2: NHE family of isoforms 
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